Evidence map›Paper›PMID 36454439›Full record

ArticleJournal of endocrinological investigation2023

TLR4 polymorphism and haplotype are associated with obesity and lipid profile in young population: a pilot study.

R Rodríguez-García, M Vazquez-Villamar, G Aparicio-Ozores, I Parra-Rojas, R B Radilla-Vázquez, N Castro-Alarcón

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of endocrinological investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Toll Like Receptor 4: A Potential Link Between Obesity and Metabolic Diseases.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. International journal of general medicine · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

R Rodríguez-GarcíaLaboratorio de Clínico, Instituto Mexicano del Seguro Social, Hospital General Regional, #1. Av. Plan de Ayala S/N, C.P. 62450, Cuernavaca Morelos, Mexico.
M Vazquez-VillamarLaboratorio de Investigación en Microbiología. Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, México. Av. Lázaro Cárdenas S/N, Ciudad Universitaria Sur Col. Haciendita, C. P. 39090, Chilpancingo, Guerrero, México.
G Aparicio-OzoresDepartamento de Microbiología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional. Avenida Plan de Ayala S/N, Col., C. P. 39610, Ciudad de México, México.
I Parra-RojasLaboratorio de Investigación en Obesidad y Diabetes. Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Chilpancingo, Guerrero, México.
R B Radilla-VázquezPrograma de la Doctorado en Ciencias Biomédicas. Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, México. Av. Lázaro Cárdenas S/N, Ciudad Universitaria, C. P. 39090, Chilpancingo, Guerrero, México.
N Castro-AlarcónLaboratorio de Investigación en Microbiología. Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, México. Av. Lázaro Cárdenas S/N, Ciudad Universitaria Sur Col. Haciendita, C. P. 39090, Chilpancingo, Guerrero, México. natividadcastro@uagro.mx.ORCID http://orcid.org/0000-0003-1238-7233
Universidad Autónoma de Guerrero · MXInstituto Politécnico Nacional · MXMexican Social Security Institute · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe single nucleotide polymorphisms in the TLR4 gene can decrease or increase the response to lipopolysaccharide, increasing the susceptibility to inflammatory diseases, affecting the expression or receptor function by inducing a low-grade chronic inflammatory response. PURPOSE: The objective of this study was to evaluate the association of SNPs - 2570 A > G (rs2737190), - 2081 G > A (rs10983755), 896 A > G (rs 4986790), and 1196 C > T (rs4986791) of the TLR4 gene with obesity and metabolic alterations in the young population.

resultsIn this study, it was found that the carriers of the heterozygous genotype of the SNPs - 2081 G > A, 896 A > G, and 1196 C > T confer a higher risk of developing obesity (OR = 3.73, p = 0.018; OR = 5.66, p = 0.014, and OR = 8.95, p = 0.014, respectively). Also, with the lipid profile, the SNP - 2081 G > A was associated with total cholesterol (TC) ≥ 200 mg/dL (OR = 3.91, p = 0.020) and Kannel index > 3% (OR = 4.00, p = 0.008). The SNP 896 A > G was associated with LDL-c ≥ 100 mg/dL (OR = 3.64, p = 0.040) and Kannel index > 3% (OR = 4.33, p = 0.016), and the SNP 1196 C > T was associated with TC ≥ 200 mg/dL (OR = 4.37, p = 0.048), Castelli index > 4.5/> 5% (OR = 5.33, p = 0.016), and Kannel index > 3% (OR = 16.00, p = 0.001). Finally, the AGGT haplotype was associated with Castelli index > 4.5/> 5% (OR = 5.40, p = 0.015) and Kannel index > 3% (OR = 10.46, p < 0.001), and the AAAC haplotype was associated with obesity (OR = 3.56, p = 0.020), TC ≥ 200 mg/dL (OR = 4.04, p = 0.007), LDL-c ≥ 100 mg/dL (OR = 2.98, p = 0.030) and Kannel index > 3% (OR = 4.20, p = 0.002).

conclusionThe heterozygous genotype of the SNPs - 2081 G > A, 896 A > G and 1196 C > T of the TLR4 gene was associated with altered lipid profile and development of obesity in young university students of Guerrero State, Mexico.

Indexed as

ObesityToll-Like Receptor 4Cholesterol, LDLGenetic Predisposition to DiseaseGenotypeHaplotypesHumansPilot ProjectsPolymorphism, Single NucleotideCholesterol, LDLTLR4 protein, humanToll-Like Receptor 4Lipid profileObesityPolymorphismTLR4 gene

Identifiers

PMID36454439
OpenAlexW4310524831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.